跳至主要内容
临床试验/IRCT20201220049774N1
IRCT20201220049774N1尚未招募3 期

Evaluation of the effect of tizanidine administration on acute pain control after CABG in adult patients: A randomized placebo-controlled clinical trial

Mashhad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients hospitalized for CABG surgery in the age range of 18 to 65 years receiving standard medication regimen (Aspirin, P2Y12 platelet receptor blockers, angiotensin-converting enzyme inhibitors, beta-blockers, and statins)
  • Signing the informed consent form by the patient

排除标准

  • severe renal failure (CrCl <25 ml/min)
  • Severe hepatic impairment (patients with class C hepatic impairment based on Child-Pugh classification with a score of 10-15 based on the parameters of ascites, bilirubin, albumin, INR and encephalopathy)
  • History of hypersensitivity reactions to tizanidine
  • History of drug or alcohol addiction
  • Low arterial blood pressure (SBP <90 mmHg or MAP <65 mmHg)
  • Concomitant use of dexmedetomidine
  • Chronic pain
  • Taking painkillers 24 hours before surgery
  • Neuromuscular disease
  • Class IV (severe) heart failure according to the New York Heart Association classification
  • Receiving ciprofloxacin during hospitalization
  • Pregnancy or breastfeeding

研究者

相似试验

Effect of tizanidine on pain after cardiac surgery | 临床试验